Valued Wealth Advisors LLC
Position in GLUE — Monte Rosa Therapeutics, Inc.
CIK 2007175
HOLLADAY, UT
Position in GLUE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$943
New position
Shares Held
39
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#186
of 191 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Valued Wealth Advisors LLC holds $51,022 across 9 Biotechnology names. GLUE ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35 | $17,385 | |
| 2 | HRMY |
Harmony Biosciences Holdings, Inc.
|
351 | $12,779 | |
| 3 | EXEL |
Exelixis, Inc.
|
119 | $6,474 | |
| 4 | 158 | $4,965 | |||
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
20 | $4,819 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4 | $2,494 | |
| 7 | INVA |
Innoviva, Inc.
|
42 | $953 | |
| 8 | GLUE |
Monte Rosa Therapeutics, Inc.
This page
|
39 | $943 |
All Filings in GLUE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $943 | 39 | Shares | Sole | 2026-07-21 | |
| No filing history on record for this holder in this stock. | ||||||